The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
- PMID: 22270043
- DOI: 10.1016/j.pneurobio.2012.01.003
The ubiquitin proteasome system in neurodegenerative diseases: culprit, accomplice or victim?
Abstract
A shared hallmark for many neurodegenerative disorders is the accumulation of toxic protein species which is assumed to be the cause for these diseases. Since the ubiquitin proteasome system (UPS) is the most important pathway for selective protein degradation it is likely that it is involved in the aetiology neurodegenerative disorders. Indeed, impairment of the UPS has been reported to occur during neurodegeneration. Although accumulation of toxic protein species (amyloid β) are in turn known to impair the UPS the relationship is not necessarily causal. We provide an overview of the most recent insights in the roles the UPS plays in protein degradation and other processes. Additionally, we discuss the role of the UPS in clearance of the toxic proteins known to accumulate in the hallmarks of neurodegenerative diseases. The present paper will focus on critically reviewing the involvement of the UPS in specific neurodegenerative diseases and will discuss if UPS impairment is a cause, a consequence or both of the disease.
Copyright © 2012 Elsevier Ltd. All rights reserved.
Similar articles
-
Does impairment of the ubiquitin-proteasome system or the autophagy-lysosome pathway predispose individuals to neurodegenerative disorders such as Parkinson's disease?J Alzheimers Dis. 2010;19(1):1-9. doi: 10.3233/JAD-2010-1231. J Alzheimers Dis. 2010. PMID: 20061621 Review.
-
Dysfunction of the ubiquitin-proteasome system in multiple disease conditions: therapeutic approaches.Bioessays. 2008 Nov;30(11-12):1172-84. doi: 10.1002/bies.20852. Bioessays. 2008. PMID: 18937370 Review.
-
The aggravating role of the ubiquitin-proteasome system in neurodegeneration.FEBS Lett. 2005 Jan 31;579(3):571-6. doi: 10.1016/j.febslet.2004.12.058. FEBS Lett. 2005. PMID: 15670810 Review.
-
The neuronal ubiquitin-proteasome system: murine models and their neurological phenotype.Prog Neurobiol. 2008 Jun;85(2):176-93. doi: 10.1016/j.pneurobio.2008.03.001. Epub 2008 Mar 18. Prog Neurobiol. 2008. PMID: 18448229 Review.
-
Fluorescent reporters for the ubiquitin-proteasome system.Essays Biochem. 2005;41:113-28. doi: 10.1042/EB0410113. Essays Biochem. 2005. PMID: 16250901 Review.
Cited by
-
Localization of mutant ubiquitin in the brain of a transgenic mouse line with proteasomal inhibition and its validation at specific sites in Alzheimer's disease.Front Neuroanat. 2015 Mar 17;9:26. doi: 10.3389/fnana.2015.00026. eCollection 2015. Front Neuroanat. 2015. PMID: 25852488 Free PMC article.
-
Target- and mechanism-based therapeutics for neurodegenerative diseases: strength in numbers.J Med Chem. 2013 Apr 25;56(8):3121-47. doi: 10.1021/jm3015926. Epub 2013 Mar 27. J Med Chem. 2013. PMID: 23458846 Free PMC article. Review.
-
A decline in PABPN1 induces progressive muscle weakness in oculopharyngeal muscle dystrophy and in muscle aging.Aging (Albany NY). 2013 Jun;5(6):412-26. doi: 10.18632/aging.100567. Aging (Albany NY). 2013. PMID: 23793615 Free PMC article.
-
Dysfunction of Protein Quality Control in Parkinsonism-Dementia Complex of Guam.Front Neurol. 2018 Mar 20;9:173. doi: 10.3389/fneur.2018.00173. eCollection 2018. Front Neurol. 2018. PMID: 29615966 Free PMC article.
-
Metabolism of minor isoforms of prion proteins: Cytosolic prion protein and transmembrane prion protein.Neural Regen Res. 2013 Oct 25;8(30):2868-78. doi: 10.3969/j.issn.1673-5374.2013.30.009. Neural Regen Res. 2013. PMID: 25206608 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical